<DOC>
	<DOCNO>NCT00000302</DOCNO>
	<brief_summary>The purpose study compare liquid tablet buprenorphine formulation .</brief_summary>
	<brief_title>Study Comparing Liquid Tablet Buprenorphine Formulations - 5</brief_title>
	<detailed_description>Participants induct either liquid tablet buprenorphine , double-blind , double-dummy manner . They reach steady state second week , schedule blood draw week 3 , 4 , 7 , 8 , 11 , 12 , 15 , 16 .</detailed_description>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>M/F age 2150 . Opiate dependence accord DSMIV criterion . Currently enrol outpatient protocol compare liquid tablet formulation Buprenorphine . Agreeable condition study sign informed consent . Psychiatric disorder require medication therapy . History seizure . Pregnant and/or nursing woman . Dependence ETOH benzodiazepine sedativehypnotics . Acute hepatitis . Other medical condition deem participation unsafe .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2002</verification_date>
</DOC>